Lv1
20 积分 2025-05-01 加入
Astragaloside IV Mitigated Diabetic Nephropathy by Restructuring Intestinal Microflora and Ferroptosis
1个月前
已完结
Astragaloside IV Exhibited Antidiabetic Effects by Improving Glucose Metabolism, Repairing Damaged Gut Barrier and Regulating Intestinal Microbiota
1个月前
已完结
Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
3个月前
已完结
A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy
7个月前
已完结
Integrating network pharmacology, molecular docking and simulation approaches with machine learning reveals the multi-target pharmacological mechanism of Berberis integerrima against diabetic nephropathy
7个月前
已完结
Integrated metabolomics and network pharmacology analysis of Yulan Jiangtang capsules in diabetic nephropathy
7个月前
已完结
Mechanism of Astragaloside IV in Treatment of Renal Tubulointerstitial Fibrosis
7个月前
已完结
Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease
8个月前
已完结
Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization
8个月前
已完结
Corrigendum to: “Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway” [J. Ethnopharmacol. 281 (2021) 114558]
8个月前
已完结
皖公网安备34019202002308
